Styx Biotechnologies

Biotechnology Research • San Diego, California, United States • 1-10 Employees

Company overview

Headquarters	San Diego, California, United States
NAICS	541714
Founded	2021
Employees	1-10

Key Contact at Styx Biotechnologies

Ashutosh Tiwari

Co-Founder & CEO

About Styx Biotechnologies

Styx, a pioneering biotech startup, is committed to transforming immunotherapy and cancer vaccine development by emphasizing enhanced immune memory for cancer treatment and prevention, particularly for challenging cancer types. The company's pipeline includes innovative CAR-T cell therapy product candidates targeting both solid and liquid tumors, as well as vaccine candidates addressing patient populations with high unmet medical need. With a mission to develop safer, more effective, and long-lasting immunotherapies and vaccines, Styx Biotechnologies is dedicated to improving global health outcomes and fostering a healthier future for all.

Styx Biotechnologies revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Styx Biotechnologies has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Styx Biotechnologies has never raised funding before.

Frequently asked questions

Styx Biotechnologies is located in San Diego, California, US.

Styx Biotechnologies was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Styx Biotechnologies has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Styx Biotechnologies

Ashutosh Tiwari

Co-Founder & CEO

4.8

40,000 users